Memberships and roles in committees:

National level:

BioNanoNet is contributing to several working groups that are part of the Austrian Cluster Platform and brings its scientifically based know-how into this platform.

You may find an article about the 5th Austrian Cluster Conference of the National Cluster Platform Austria in our BioNanoNet newsletter 04/2014 on page 23.

BioNanoNet supports the Austrian research community by participating in the national working group and shaping the call topics for European Calls.

The Austrian Nano Information Commission (NIK) is a formal collaboration of stakeholders working in nanotechnology that provides a structured process of communication among experts. It allows them to merge communications in a transparent matter and functions as a contact point for policy makers in order to provide information for courses of action.

In order to hold an unprejudiced discussion about the possible social opportunities and risks of nanotechnologies with respect to their consumer applications, early and open communication is critical. Therefore, the NIK acts as a  guide for policy makers and public authorities and allows them to provide  advice on nanotechnological issues in Austria. The first course of action was the formal inauguration of the head and members of the NIK by the director of the Federal Ministry of Health, Mr. Alois Stöger, on November 13, 2013, in Vienna. For more details, please see our BioNanonet Newsletter 04/2013 (page 25).

BioNanoNet is permanent member of the NanoInformationsKommission-Plenum group.

International level:

BioNanoNet is member of the Management Committee in COST Action CA15114 AMiCI
MC-Member: Susanne Resch
MC-Substitute: Andreas Falk
WG1: Antimicrobial materials Safe by Design
WG3: Adverse effects/Risk-Benefit analysis
WG5: Communication and dissemination

BioNanoNet is member of the Management Committee in COST-Action CA15107 MULTICOMP.

MC-Member: Christa Schimpel
MC-Substitute: Susanne Resch

WG3: Characterization, Health, Safety and Environment (HSE)

COST Action CA17140 is the first, pan-European interdisciplinary network of representatives from academic institutions and small and medium enterprises including clinical research organizations (CROs) devoted to the development of nanosystems carrying anticancer drugs from their initial design, pre-clinical testing of efficacy, pharmacokinetics and toxicity to the preparation of detailed protocols needed for the first phase of their clinical studies.

By promoting scientific exchanges, technological implementation and innovative solutions, the Action will provide a timely instrument to rationalize and focus research efforts at the EU level in dealing with the grand challenge of nanomedicine translation in cancer, one of the major and societal-burdening human pathologies.


BioNanoNet is member of the Management Committee in COST-Action CA17140 Nano2Clinic.
MC-Member: Andreas Falk
MC-Substitute: Susanne Resch

BioNanoNet is member of the Management Committee in COST-Action MP1404 SimInhale

MC-Member: Eleonore Fröhlich
MC-Substitute: Christa Schimpel
WG4: Advanced imaging, patient monitoring and delivery verification
WG5: Toxicity, xenobiotics, risk assessment and policy development 

BioNanoNet is member of the Management Committee in COST-Action CM1403 UPCON.

MC-Member: Andreas Falk
MC-Substitute: Christa Schimpel

Download pdffinal COST Action CM1403 Report

BNN is functioning as digital innovation hub.
The activities of the hub are well aligned with the Austrian national initiative for digitising industry, Industrie 4.0 Oesterreich and the Digital Roadmap. Furthermore, BioNanoNet supports the initiative European Open Science Cloud.

As part of European Technology Platform Sustainable Chemistry (SusChem) BioNanoNet supports the strategic development (e.g. in the field of process technologies, digital technologies) on European level, as well as on national level by coordinating the Austrian national technology platform SusChem-AT. Both activities are linked to the respective governmental parts, the European Commission on European level; the Austrian ministries on national level, and the provincal government (e.g. Styria) on regional level.

In addition to the sustainable chemistry activities, BioNanoNet also supports the further development of the sensortechnology field in Austria  and Europe (e.g. EU-FP7-project SPIDIMAN; EU-H2020-project R2R Biofluidics). One initiative which combines regional with national experts to close gaps along the value chain and to support industrial innovation is the Austrian Microfluidics Initiative, also coordinated by the DIH BioNanoNet. For further information, please see
Click HERE to learn more about the Pan-European network of Digital Innovation Hubs (DIHs).

The European Society for Nanomedicine is a society of individuals and bodies across Europe that focuses on the clinical application of nanomedicine and its implications for individuals and society. Through this focus, it complements a number of already existing European platforms, initiatives, and framework-programmes that see their main task in linking researchers and industry.

SusChem is the European Technology Platform for Sustainable Chemistry. It is a forum that brings together industry, academia, governmental policy groups and the wider society. SusChem’s mission is to initiate and inspire European chemical and biochemical innovation to respond effectively to society’s challenges by providing sustainable solutions.
BioNanoNet is coordinator of the Austrian national technology platform SusChem-AT (
Further information:

The ETPN is an important European Technology Platform that contributes to the advancement nanomedicine in Europe.

BioNanoNet is member of the Executive Board of the ETPN and chair of the working group on safety and characterisation in nanomedicine (former WG toxicology and characterisation).

BioNanoNet is coordinator of the Austrian national technology platform NanoMedicine-Austria. Further information:

BioNanoNet is member of ETPIS.

More information about ETPIS:

BioNanoNet is member of the General Board of the NANOfutures a.s.b.l. and is a member of several working groups that are part of this network, active world-wide.

All Nanosafety-relevant European projects are connected to each other in the NanoSafetyCluster (NSC).

BioNanoNet is member of the Coordination Team.

The coordination team consist of Eva Valsami-Jones (University of Birmingham, UK; coordinator), Iseult Lynch (University of Birmingham, UK), Andreas Falk (BioNanoNet BioNanoNet Forschungsgesellschaft, Graz) and Flemming Cassee (National Institute for Public Health and the Environment RIVM, Bilthoven, Netherlands).  The team will get secretarial support via H2020 project ACEnano for the coming years.

The role of the Coordination team is to:

  • Support for WGs and TFs, communication group and Innovation Governance
  • Facilitate key NSC decisions via online voting to enhance member participation
  • Facilitate enhanced transparency around membership of WGs and cluster activities
  • Support to the NSC projects for implementation of Core activity, and where no project available to sponsor a Core activity the Coordination team will bridge the gap.
  • Organization of biannual NSC plenary meetings (which will be mainly hands-on events designed to build consensus on key topics) as well as providing updates to the wider NSC membership , including preparation of agendas together with Steering group and the Commission
  • Preparation of the minutes from meetings of Steering group and NSC plenary meeting
  • Maintaining communication between members of the Steering group, WGs, TFs, CoRs,
  • Conducting special tasks such as publishing NSC documents, liaising with EC4SafeNano, etc.
  • Supporting the development of the strategy for the transition to an innovation governance platform.

BioNanoNet is involved as one of Austria`s designated contact points in the "Working Party on Manufactured Nanomaterials" (WPMN).